Varadha Balaji Venkadakrishnan, PhD

Instructor

Balaji_Venkadakrishnan_PhD

I am interested in understanding mechanisms of treatment-resistance and developing novel therapeutic strategies for AR- indifferent prostate cancer.
​
​​Awards

  • National Cancer Center Fellowship
  • DoD PCRP Early Investigator Research Award
  • Prostate Cancer Foundation Young Investigator Award​

Select Publications: 

  1. Venkadakrishnan VB et al. AR-dependent phosphorylation and phosphoproteome targets in prostate cancer. Endocrine-related Cancer (2020)
  2. Venkadakrishnan VB et al. Protein kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy. Oncogene (2019)
  3. Venkadakrishnan VB, Yamada Y, Weng K, Idahor O, Beltran H. Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers. Mol Cancer Res (2023)​
  4. Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, Voss NCE, Mahadevan NR, Mizuno K, Puca L, Idahor O, Ku SY, Bakht MK, Borah AA, Herbert ZT, Tolstorukov MY, Barbie DA, Rickman DS, Brown M, Beltran H. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nat Commun. (2024)